Target Specific Compound Identification Using a Support Vector Machine

Abstract

In many cases at the beginning of an HTS-campaign, some information about active molecules is already available. Often known active compounds (such as substrate analogues, natural products, inhibitors of a related protein or ligands published by a pharmaceutical company) are identified in low-throughput validation studies of the biochemical target. In this study we evaluate the effectiveness of a support vector machine applied for those compounds and used to classify a collection with unknown activity. This approach was aimed at reducing the number of compounds to be tested against the given target. Our method predicts the biological activity of chemical compounds based on only the atom pairs (AP) two dimensional topological descriptors. The supervised support vector machine (SVM) method herein is trained on compounds from the MDL drug data report (MDDR) known to be active for specific protein target. For detailed analysis, five different biological targets were selected including cyclooxygenase-2, dihydrofolate reductase, thrombin, HIV-reverse transcriptase and antagonists of the estrogen receptor. The accuracy of compound identification was estimated using the recall and precision values. The sensitivities for all protein targets exceeded 80% and the classification performance reached 100% for selected targets. In another application of the method, we addressed the absence of an initial set of active compounds for a selected protein target at the beginning of an HTS-campaign. In such a case, virtual high-throughput screening (vHTS) is usually applied by using a flexible docking procedure. However, the vHTS experiment typically contains a large percentage of false positives that should be verified by costly and time-consuming experimental follow-up assays. The subsequent use of our machine learning method was found to improve the speed (since the docking procedure was not required for all compounds from the database) and also the accuracy of the HTS hit lists (the enrichment factor).

The interactome: Predicting the protein-protein interactions in cells

“…Up to now, all the computational algorithms have only used single machine learning methods for the analysis and prediction of protein-protein interactions [156][157][158][159][160], or the statistical analysis of interacting patches of protein surfaces [75,149,161,162]. Our experience clearly supports the idea that each machine learning algorithm performs better for selected types of training data [163,164]. Some have very high specificity, others focus more on sensitivity.…”

Data mining PubChem using a support vector machine with the Signature molecular descriptor: Classification of factor XIa inhibitors

“…Training a SVM has become a popular technique in cheminformatic applications. It has been used to predict various properties for small molecules including biological activity [13][14][15][16][17][18][19], metabolism by cytochrome P450 [20][21][22], toxicity [23,24], and blood-brain barrier penetration [25]. As SVMs have outperformed other statistical learning methods [14,25], we will use it in this work.…”

LASSO-ing Potential Nuclear Receptor Agonists and Antagonists: A New Computational Method for Database Screening

“…For example, a recent QSAR analysis of 74 natural or synthetic estrogens provided information on structural features for the activation of ER and ER [30]. Nonlinear statistical machine learning methods have been applied to separate NR activators from nonactivators [31]. A virtual screening protocol identified ER specific ligands from a plant product-based database [32]; from 12 candidates evaluated by a fluorescence polarization binding assay, 3 had >100-fold selectivity to ER over ER .…”